Not applicableStudy completedNCT02694172What this trial is testingHuman Faecal Microbiota in Type 2 DiabetesWho this might be right forType 2 DiabetesHealthyOverweight Société des Produits Nestlé (SPN) 67
Not applicableNot Yet RecruitingNCT07519265What this trial is testingBioequivalence Study of Chiglitazar/Metformin Extended-Release TabletsWho this might be right forT2DM (Type 2 Diabetes Mellitus) Chipscreen Biosciences, Ltd. 64
Testing effectiveness (Phase 2)Study completedNCT02218099What this trial is testingEvaluate the Pharmacokinetics, Pharmacodynamics and Safety of ASP8232 in Subjects With Renal Impairment and in Type 2 Diabetes Mellitus Subjects With Chronic Kidney DiseaseWho this might be right forHealthy SubjectsPharmacokinetics of ASP8232Pharmacodynamics of ASP8232+2 more Astellas Pharma Europe B.V. 55
Early research (Phase 1)Study completedNCT04259801What this trial is testingFirst Research Study to Look at How Two Medicines, NNC0480-0389 and Semaglutide, Work Together in Healthy People, in People With High Body Weight and in People With DiabetesWho this might be right forHealthy VolunteersOverweightObesity+1 more Novo Nordisk A/S 152
Early research (Phase 1)Study completedNCT07304687What this trial is testingClinical Study to Evaluate the Pharmacokinetics and Safety of CKD-383 0.5/25/1000mg in Healthy VolunteersWho this might be right forType 2 Diabetes Chong Kun Dang Pharmaceutical 31
Early research (Phase 1)Study completedNCT07304700What this trial is testingClinical Study to Evaluate the Pharmacokinetics and Safety of CKD-383 0.5/10/1000mg in Healthy VolunteersWho this might be right forType 2 Diabetes Chong Kun Dang Pharmaceutical 30
Not applicableNot Yet RecruitingNCT07412015What this trial is testingPilot Bioequivalence Study of Chiglitazar/Metformin Extended-Release TabletsWho this might be right forT2DM (Type 2 Diabetes Mellitus) Chipscreen Biosciences, Ltd. 24
Early research (Phase 1)Study completedNCT01432938What this trial is testingThe Effect of Dulaglutide on the Action of Warfarin in Healthy ParticipantsWho this might be right forDiabetes Mellitus, Type 2 Eli Lilly and Company 28
Early research (Phase 1)Study completedNCT05491421What this trial is testingZT002 in Healthy ParticipantsWho this might be right forType 2 Diabetes Mellitus QL Biopharmaceutical Australia Pty Ltd 32
Early research (Phase 1)Study completedNCT02722239What this trial is testingAn Open-label, Randomized, Crossover Study of Comparative Pharmacokinetics and Bioequivalence of Dapagliflozin + Metformin, 10 mg + 1000 mg Versus the Combined Use of Forxiga™, 10 mg and Two Glucophage® Long, ER Tablets, 500 mg Co-administered to Healthy Volunteers Under Standard Fed ConditionsWho this might be right forDiabetes Mellitus, Type 2 AstraZeneca 40
Early research (Phase 1)Study completedNCT00937872What this trial is testingA Clinical Study to Evaluate the Pharmacokinetics and the Absolute Bioavailability of SRT2104 Given as a 250mg Oral Suspension and Intravenous Microdose of 100 µg Carbon-14 Radio-labeled SRT2104 in Healthy Male SubjectsWho this might be right forDiabetes Mellitus, Type 2 Sirtris, a GSK Company 9
Early research (Phase 1)Study completedNCT05411965What this trial is testingEvaluate the Pharmacokinetics After Administration of BR3003 and Co-administration of BR3003B and BR3003C.Who this might be right forDiabetes Mellitus, Type 2 Boryung Pharmaceutical Co., Ltd 48
Early research (Phase 1)Study completedNCT04586907What this trial is testingLY3537021 in Healthy Participants and Participants With Type 2 Diabetes MellitusWho this might be right forHealthyType 2 Diabetes Mellitus Eli Lilly and Company 85
Early research (Phase 1)Study completedNCT02373150What this trial is testingSafety, Tolerability and PK of Imeglimin in Japanese VolunteersWho this might be right forType 2 Diabetes Mellitus Poxel SA 48
Early research (Phase 1)Study completedNCT05682495What this trial is testingA HR20031 BE Study on Healthy SubjectsWho this might be right forType 2 Diabetes Shandong Suncadia Medicine Co., Ltd. 96
Early research (Phase 1)Study completedNCT06204107What this trial is testingA Clinical Trial to Evaluate the Food Effect on Pharmacokinetic Profiles and Safety of CKD-379Who this might be right forType 2 Diabetes Mellitus Chong Kun Dang Pharmaceutical 28
Early research (Phase 1)Study completedNCT04907019What this trial is testingA Drug Interaction Study of SY-004 Capsules in Healthy SubjectsWho this might be right forType 2 Diabetes Suzhou Yabao Pharmaceutical R&D Co., Ltd. 24
Very early researchStudy completedNCT03479671What this trial is testingLow Dose Fat-Induced Insulin ResistanceWho this might be right forDiabetes Mellitus, Type 2Insulin ResistanceInsulin Sensitivity University of Pennsylvania 9
Early research (Phase 1)Study completedNCT00607906What this trial is testingFirst-Time-in-Humans Study to Assess Safety, Pharmacokinetics & Pharmacodynamics of SB756050Who this might be right forDiabetes Mellitus, Type 2 GlaxoSmithKline 36
Early research (Phase 1)Study completedNCT02039258What this trial is testingPharmacokinetics of a Fixed Dose Combination of Canagliflozin/Metformin Coadministered With FoodWho this might be right forHealthy Volunteers Janssen Research & Development, LLC 24